Correction: Serum 25-Hydroxyvitamin D Concentrations ≥40 ng/ml Are Associated with >65% Lower Cancer Risk: Pooled Analysis of Randomized Trial and Prospective Cohort Study

This 2018 correction pertains to the 2016 study that pooled data from a randomized clinical trial and a prospective cohort to assess the relationship between serum 25-hydroxyvitamin D [25(OH)D] levels and cancer risk in women aged 55 and older. The original analysis demonstrated that women with serum 25(OH)D concentrations ≥40